Chromosome 1q25.3 copy number alterations in primary breast cancers detected by multiplex ligation-dependent probe amplification and allelic imbalance assays and its comparison with fluorescent in situ hybridization assays

Cellular Oncology

Volumn 36, Issue 2, 2013, Pages 113-120

  Wiechec, Emilia ^a,b,c   Overgaard, Jens ^b   Kjeldsen, Eigil ^b   Hansen, Lise Lotte ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c LINKÖPING UNIVERSITY   (Sweden)

Author keywords

Allelic imbalance (AI); Breast cancer; Fluorescent in situ hybridization (FISH); Multiplex ligation dependent probe amplification (MLPA); RGS genes

Indexed keywords

ALLELIC IMBALANCE; ARTICLE; BREAST CANCER; CHROMOSOME 1Q; CHROMOSOME DELETION; CHROMOSOME LOSS; CONTROLLED STUDY; COPY NUMBER VARIATION; FLUORESCENCE IN SITU HYBRIDIZATION; GENE DOSAGE; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; METAPHASE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; PRIORITY JOURNAL;

ALLELIC IMBALANCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 1; DNA COPY NUMBER VARIATIONS; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MULTIPLEX POLYMERASE CHAIN REACTION; PROTEINS; REPRODUCIBILITY OF RESULTS; RGS PROTEINS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS;

EID: 84876476109     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-012-0117-1     Document Type: Article

References (27)

1. R. Roylance, P. Gorman, W. Harris, R. Liebmann, D. Barnes, A. Hanby et al., Comparative genomic hybridization of breast tumours stratified by histological grade reveals new insights into the biological progression of breast cancer. Cancer Res. 59, 1433-1436 (1999)
2. M.R. Teixeira, N. Pandis, S. Heim, Cytogenetic clues to breast carcinogenesis. Gene Chromosome Cancer 33, 1-16 (2002)
3. B. Orsetti, M. Nugoli, N. Cervera, L. Lasorsa, P. Chuchana, C. Rouge et al., Genetic profiling of chromosome 1 in breast cancer: mapping of regions of gains and losses and identification of candidate genes on 1q. Br. J. Cancer 95, 1439-1447 (2006)
4. H. Tsarouha, N. Pandis, G. Bardi, M.R. Teixeira, J.A. Andersen, S. Heim, Karyotypic evolution in breast carcinomas with i(1)(q10) and der(1;16)(q10;p10) as the primary chromosome abnormality. Cancer Genet. Cytogenet. 113, 156-161 (1999)
5. K. Friedrich, A. von Heydebreck, G. Haroske, J. Scheithauer, W. Meyer, K.D. Kunze et al., Comparative genomic hybridization-based oncogenetic tree model for genetic classification of breast cancer. Anal. Quant. Cytol. Histol. 31, 101-108 (2009)
6. E. Stacher, V. Boldt, S. Leibl, I. Halbwedl, H.H. Popper, R. Ullmann et al., Chromosomal aberrations as detected by array comparative genomic hybridization in early low-grade intraepithelial neoplasias of the breast. Histopathology 59, 549-555 (2011)
7. H. Tsuda, T. Takarabe, T. Fukutomi, S. Hirohashi, der(16)t(1;16)/ der(1;16) in breast cancer detected by fluorescence in situ hybridization is an indicator of better patient prognosis. Gene Chromosome Cancer 24, 72-77 (1999)
8. F. Farabegoli, M.A. Hermsen, C. Ceccarelli, D. Santini, M.M. Weiss, G.A. Meijer et al., Simultaneous chromosome 1q gain and 16q loss is associated with steroid receptor presence and low proliferation in breast carcinoma. Mod. Pathol. 17, 449-455 (2004)
9. K. Rennstam, M. Ahlstedt-Soini, B. Baldetorp, P.O. Bendahl, A. Borg, R. Karhu et al., Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumours by comparative genomic hybridization. Cancer Res. 63, 8861-8868 (2003)
10. E.A. Janssen, J.P. Baak, M.A. Guervos, P.J. van Diest, M. Jiwa, M.A. Hermsen, In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor. J. Pathol. 201, 555-561 (2003)
11. P. Devilee, M. van Vliet, A. Bardoel, T. Kievits, N. Kuipers-Dijkshoorn, P.L. Pearson et al., Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma. Cancer Res. 51, 1020-1025 (1991)
12. A. Borg, Q.X. Zhang, H. Olsson, E. Wenngren, Chromosome 1 alterations in breast cancer: allelic loss on 1p and 1q is related to lymphogenic metastases and poor prognosis. Gene Chromosome Cancer 5, 311-320 (1992)
13. V. Gaki, M. Tsopanomichalou, G. Sourvinos, D. Tsiftsis, D.A. Spandidos, Allelic loss in chromosomal region 1q21-23 in breast cancer is associated with peritumoural angiolymphatic invasion and extensive intraductal component. Eur. J. Surg. Oncol. 26, 455-460 (2000)
14. L.C. Chen, C. Dollbaum, H.S. Smith, Loss of heterozygosity on chromosome 1q in human breast cancer. Proc. Natl. Acad. Sci. U. S. A. 86, 7204-7207 (1989)
15. I. Bieche, M.H. Champeme, R. Lidereau, Loss and gain of distinct regions of chromosome 1q in primary breast cancer. Clin. Cancer Res. 1, 123-127 (1995)
16. E. Wiechec, J. Overgaard, L.L. Hansen, A fragile site within the HPC1 region at 1q25.3 affecting RGS16, RGSL1, and RGSL2 in human breast carcinomas. Gene Chromosome Cancer 47, 766-780 (2008)
17. J.P. Schouten, C.J. McElgunn, R. Waaijer, D. Zwijnenburg, F. Diepvens, G. Pals, Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res. 30, e57 (2002)
18. C.B. Moelans, R.A. de Weger, H.N. Monsuur, R. Vijzelaar, P.J. van Diest, Molecular profiling of invasive breast cancer by multiplex ligation-dependent probe amplification-based copy number analysis of tumour suppressor and oncogenes. Mod. Pathol. 23, 1029-1039 (2010)
19. C.B. Moelans, R.A. de Weger, H.N. Monsuur, A.H. Maes, P.J. van Diest, Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study. Anal. Cell Pathol. (Amst.) 33, 165-173 (2010)
20. C.B. Moelans, R.A. de Wegers, H.N. Monsuurs, A.H. Maess, P.J. van Diest, Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study. Cell Oncol. (Dordr.) 34, 475-482 (2011)
21. L.L. Hansen, J. Andersen, J. Overgaard, T.A. Kruse, Molecular genetic analysis of easily accessible breast tumour DNA, purified from tissue left over from hormone receptor measurement. APMIS 106, 371-377 (1998)
22. K. Pedersen, E. Wiechec, B.E. Madsen, J. Overgaard, L.L. Hansen, A simple way to evaluate self-designed probes for tumour specific multiplex ligation-dependent probe amplification (MLPA). BMC Res. Notes 3, 179 (2010)
23. S. Kytola, J. Rummukainen, A. Nordgren, R. Karhu, F. Farnebo, J. Isola et al., Chromosomal alterations in 15 breast cancer cell lines by comparative genomic hybridization and spectral karyotyping. Gene Chromosome Cancer 28, 308-317 (2000)
24. I. Bieche, M.H. Champeme, F. Matifas, C.S. Cropp, R. Callahan, R. Lidereau, Two distinct regions involved in 1p deletion in human primary breast cancer. Cancer Res. 53, 1990-1994 (1993)
25. Y. Utada, M. Emi, M. Yoshimoto, F. Kasumi, F. Akiyama, G. Sakamoto et al., Allelic loss at 1p34-36 predicts poor prognosis in node-negative breast cancer. Clin. Cancer Res. 6, 3193-3198 (2000)
26. C.A. Koch, S.C. Huang, J.F. Moley, N. Azumi, G.P. Chrousos, R.F. Gagel et al., Allelic imbalance of the mutant and wild-type RET allele in MEN 2A-associated medullary thyroid carcinoma. Oncogene 20, 7809-7811 (2001)
27. Z. Zhuang, P. Bertheau, M.R. Emmert-Buck, L.A. Liotta, J. Gnarra, W.M. Linehan et al., A microdissection technique for archival DNA analysis of specific cell populations in lesions <1 mm in size. Am. J. Pathol. 146, 620-625 (1995)